News | June 19, 2008

ECG on a Chip Technology Available to Speed Device Development

June 20, 2008 - Freescale Semiconductor and Monebo Technologies recently forged a partnership to deliver a comprehensive platform for medical equipment using electrocardiogram (ECG) on a chip technology to enable medical equipment manufacturers to develop easy-to-use ECG monitoring tools.

ECG monitors are vital tools used by healthcare providers to help identify cardiac conditions and monitor a patient's health. According to the World Health Organization, cardiovascular disease is the leading cause of death globally. An estimated 17.5 million people died from cardiovascular disease in 2005, representing 30 percent of all global deaths.

To help healthcare professionals assess cardiac parameters, Monebo Technologies has developed the Kinetic ECG algorithm, which enables signal processing and interpretation of the ECG waveform. The algorithm provides highly accurate QRS (Q wave, R wave and S wave) detection and feature extraction, beat classification, interval measurement and rhythm interpretation for up to 16 leads of captured ECG data.

Monebo’s Kinetic software runs on a broad range of Freescale microprocessors (MPUs) and microcontrollers (MCUs). These processing platform options give developers freedom of choice for their ECG applications, based on their performance, operating power, integration and system cost needs.

Today's medical device designers face the challenge of creating increasingly more complex products and bringing these products to market faster. The pairing of the Kinetic algorithm with Freescale processors enables designers to add advanced ECG monitoring functionality and get to market quickly. Freescale's embedded MPUs and MCUs contain the necessary integration to add innovative technology to next-generation medical devices, and the FDA 510(k) clearance on the Kinetic algorithm streamlines end-device regulatory filings.

For more information: www.freescale.com, www.monebo.com


Related Content

News | ECG

March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...

Home March 06, 2026
Home
News | ECG

March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home March 04, 2026
Home
News | ECG

Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...

Home February 24, 2026
Home
News | ECG

Feb. 18, 2026 — Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and ...

Home February 20, 2026
Home
News | ECG

Dec. 10, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to HeartBeam, Inc. for its 12 ...

Home February 16, 2026
Home
News | ECG

Jan. 8, 2026 — AccurKardia recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the ...

Home January 15, 2026
Home
News | ECG

Jan. 13, 2026 — AliveCor has received U.S. Food and Drug Administration (FDA) clearance for the next generation of KAI ...

Home January 14, 2026
Home
News | ECG

Oct. 8, 2025 — Viz.ai recently launched Viz ACS, a new solution in the Viz Cardio Suite. Designed to unite the acute ...

Home October 09, 2025
Home
News | ECG

Aug. 14, 2025 — During HeartBeam, Inc.'s second quarter 2025 earnings conference call, the medical technology company ...

Home August 15, 2025
Home
News | ECG

July 24, 2025 — Royal Philips has announced a collaboration with Epic to integrate Philips’ suite of cardiac ambulatory ...

Home July 24, 2025
Home
Subscribe Now